Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

What is new in the management of recurrent ovarian cancer

When should biology drive treatment decisions?


20 Oct 2018


What is new in the management of recurrent ovarian cancer


Targeted Therapy

Tumour Site

Ovarian Cancer


Iain McNeish


I.A. McNeish

Author affiliations

  • Department Of Surgery And Cancer, Imperial College London - Hammersmith Hospital, W12 0HS - London/GB


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.